Do selective cyclo-oxygenase-2 nonsteroidal anti-inflammatory agents increase the risk for acute myocardial infarction? Joseph S. Alpert Editor’s Commentary Pages: 415 - 416
Hypertension and dementia Olivier HanonMarie Laure SeuxFrançoise Forette OriginalPaper Pages: 435 - 440
Leptin: Sympathetic and cardiovascular effects Robert J. RichardsAnthony BlalockEfrain Reisin OriginalPaper Pages: 453 - 458
Newer pharmaceutical agents to treat lipid disorders Michael H. Davidson OriginalPaper Pages: 463 - 469
Estrogen therapies, lipids, and the heart disease prevention controversy Robert H. KnoppKeiko AikawaEleanor A. Knopp OriginalPaper Pages: 477 - 482
Plasma lipoprotein concentrations in ethnic populations Karol E. Watson OriginalPaper Pages: 483 - 487
Physical activity and its effects on lipids Philippe O. SzaparyLeAnne T. BloedonGary D. Foster OriginalPaper Pages: 488 - 493